Infertility Diagnostics After 35: Which Tests Reveal the True Picture of Your Reproductive Health
When a woman over 35 visits my clinic seeking fertility diagnostics, I always see the same question in her eyes. It is not the one she voices aloud regarding tests and screenings. It is the one echoing inside: "Tell me honestly, do I still have time?" And do you know what I tell them? Yes, let’s figure this out together. Without illusions, but without premature sentences either. Because diagnostics exist specifically to provide you with concrete figures instead of agonizing uncertainty.
Age and Reproductive Potential: A Frank Conversation
I work with women of various age groups, and yes, my patients include those over 40. Furthermore, in my practice, there have been successful spontaneous pregnancies in women aged 42–43 or IVF successes with their own oocytes. However, I will be honest: these are the exception rather than the rule, and success in such cases depends directly on the ovarian reserve markers identified during diagnostics.
Is There an Age Limit for IVF Programs?
There is no formal upper age limit because every case is individual. Reproductive specialists provide treatment to women aged 44 and 45 if their markers allow for a protocol with their own oocytes. However, in many countries, programs with donor oocytes are initiated immediately after age 43. Our approach is this: after age 43–44, I immediately discuss the realism of expectations. If the reserve is minimally preserved, we can attempt one protocol, but I simultaneously always ask the woman to mentally prepare for alternative options. After age 45, programs with autologous (own) cells become the exception to the rule.
Are There Successful Cases in the Older Age Category?
Yes, of course. But, for example, among my last five patients who became mothers between ages 41 and 43, there is a key point: all these women had an AMH no lower than 0.9–1.2 ng/mL, and their FSH did not exceed 10–11 mIU/mL. In other words, the biological age of their ovaries was lower than their chronological age. However, there was also a 38-year-old patient with an AMH of 0.02 ng/mL, for whom mature eggs were only retrieved after three IVF attempts. Age is important, but reserve markers are more important.
Reproductive medicine has advanced significantly; however, biological laws remain unchanged. After 35, the quality and quantity of oocytes decline, and after 40, this process accelerates considerably. Does this mean all is lost? No. But it means we must act quickly and precisely. That is why I always tell my patients: every month of delay can matter; therefore, diagnostics must be as informative as possible from the very first step. When I create a screening plan, my task is to get the full picture in the minimum amount of time. Usually, a basic complex of tests can be completed within a single menstrual cycle. Yes, exactly one. Because I understand: you don’t have time to spend months visiting doctors and repeating the same studies.
Ovarian Reserve: Three Key Indicators of Your Fertility
The main thing we need to understand at the first stage is your ovarian reserve. This is not an abstract concept, but concrete figures that show how many viable oocytes you have left and what the chances of pregnancy are. Three main parameters work here, which I evaluate in combination.
Anti-Müllerian Hormone (AMH) is the most accurate marker of ovarian reserve today. It can be tested on any day of the cycle, which is very convenient. Normal AMH values are usually in the range of 1.5 to 4 ng/mL, but nuances are important here. If a woman aged 38–40 has an AMH of 0.8–1.0 ng/mL, I am already signaling a decrease in reserve, even though the value may formally be within the lower limit of normal. With levels below 0.5 ng/mL, chances decrease significantly; in such cases, it is not only recommended not to delay IVF, but we also consider accumulation (banking) IVF protocols.
Follicle-Stimulating Hormone (FSH) must be tested strictly on day 2–3 of the menstrual cycle. This is fundamentally important because on other days of the cycle, the result will be non-informative. An FSH level up to 10 mIU/mL is considered normal. If the indicator rises above 15 mIU/mL, it indicates that the ovaries are already struggling to respond to stimulation; the body is trying to compensate for the decline in reserve with increased hormone production. At values above 20 mIU/mL, the prognosis for obtaining own oocytes unfortunately decreases significantly. Often, despite high FSH, women insist on repeated IVF attempts, but my task is to give you reality, not false expectations.
Antral Follicle Count (AFC) is conducted via ultrasound, also on day 2–5 of the cycle. The doctor counts antral follicles measuring 7–10 mm. Normally, there should be at least 5–7 in each ovary. If there are fewer than 5 in both ovaries combined, it is a sign of diminished ovarian reserve. I always evaluate this indicator together with AMH and FSH, because only a comprehensive picture provides an accurate prognosis.
Hormonal Profile: What Else Needs to Be Checked
In addition to assessing the ovarian reserve, it is important for me to understand the general hormonal background, because even with a normal reserve, hormonal imbalances can prevent pregnancy.
On day 2–3 of the cycle, along with FSH, I prescribe tests for luteinizing hormone (LH), estradiol, and prolactin. The LH to FSH ratio should be approximately 1:1 or 1:2. If LH significantly exceeds FSH, it may indicate Polycystic Ovary Syndrome (PCOS) even at your age. Estradiol on day 2–3 of the cycle should be low (usually 20–80 pg/mL). If it is elevated, it can mask the true level of FSH and provide a false picture of the reserve. Thyroid hormones are also critically important for conception and carrying a pregnancy. I always prescribe TSH, Free T4, and TPO antibodies. For pregnancy planning, TSH should be in a narrow range of 0.4–2.5 mIU/L, rather than the standard laboratory range of up to 4.0 mIU/L. This is an important point that other specialists often overlook.
Progesterone I check on day 21–23 of the cycle (with a standard 28-day cycle) or 7 days after ovulation. This test shows whether ovulation occurred and if there is enough progesterone to support a possible pregnancy. In women of advanced reproductive age, luteal phase deficiency is common, where ovulation formally occurs, but insufficient progesterone is produced.
In-Depth Diagnostics: When Basic Tests Are Not Enough
After receiving the results of the hormonal screening, additional examination may be required. It is important to understand that I do not prescribe tests for the sake of tests. Each study must answer a specific question and influence the treatment strategy.
Hemostasiogram and genetic markers of thrombophilia are necessary if there have been failed IVF attempts, missed pregnancies, or miscarriages. Disorders of the blood coagulation system can prevent embryo implantation and lead to early pregnancy loss. This examination is especially important for women over 38, whose risk of thrombotic complications is already elevated.
Immunological factors of infertility I investigate when indicated. Antiphospholipid antibodies, anti-hCG antibodies, and natural killer (NK) cells can play a role in reproductive failures. However, I consider prescribing the full spectrum of immunological studies without indications to be inappropriate. It is expensive and often non-informative.
Genetic screening includes karyotyping of both partners. With age, the risk of chromosomal abnormalities in oocytes increases, but sometimes the cause lies in structural rearrangements in the karyotype of one partner. If such changes are detected, we discuss the possibility of preimplantation genetic testing (PGT) of embryos.
Assessment of Tubal Patency and Uterine Condition
Even ideal hormonal indicators do not guarantee pregnancy if there are mechanical obstacles. Therefore, assessing the state of the uterus and fallopian tubes is mandatory in the comprehensive diagnosis of infertility.
Hysterosalpingography (HSG) or sonohysterosalpingoscopy allow for the assessment of tubal patency and the identification of uterine cavity pathology. Many of my patients over 35 have uterine fibroids, endometrial polyps, or intrauterine synechiae (adhesions). All these conditions can prevent embryo implantation. The study is conducted in the first phase of the cycle, usually on days 5–9.
However, if hormonal results show a critically low ovarian reserve and we understand that our path is IVF, checking tubal patency is still mandatory. The presence of hydrosalpinx (a blocked tube filled with fluid due to infection) can adversely affect embryo implantation. Why does a doctor plan a tubal examination if IVF is decided? If ultrasound leads the doctor to suspect hydrosalpinx, HSG may be required even if IVF is planned. The fluid in the tube can flow back into the uterus during implantation and prevent the fetus from attaching. Therefore, if hydrosalpinx is confirmed, we perform IVF and freeze the embryos, then perform surgery to remove the tube or break down adhesions for free fluid drainage, and only then perform the embryo transfer. Alternatively, we perform the surgery first and then move to IVF. Both options are possible and are discussed between the doctor and the couple.
Pelvic ultrasound I conduct at least twice per cycle: on days 2–5 to assess antral follicles and ovarian state, and on days 21–23 to assess the endometrium and exclude pathology. The thickness of the endometrium, its structure, and the presence of any masses in the ovaries—all of this matters.
In some cases, hysteroscopy with endometrial biopsy is necessary. This minimally invasive intervention allows the doctor not only to see the uterine cavity from the inside but also to take material for histological examination. This is especially important when chronic endometritis, endometrial hyperplasia, or recurrent implantation failure is suspected.
A Realistic Look at Prospects: When Own Oocytes Are Still Possible and When They Are Not
The most difficult conversation I have to lead is the conversation about the limits of the possible. After receiving all test results, the moment comes to make a decision.
If AMH is above 1.0 ng/mL, FSH is below 12 mIU/mL, and at least 5 antral follicles are counted, we have good chances of success using your own oocytes. Yes, chances decrease with age. If at age 35 the probability of a successful pregnancy in an IVF protocol is about 40–45 percent, at age 40 it is 15–20 percent, and at age 42–43, it is about 5–10 percent. But these percentages are not zero. I have patients who became mothers at age 41–42 after one or two IVF attempts with their own eggs.
When AMH drops below 0.1 ng/mL, FSH rises above 18–20 mIU/mL, and follicles on ultrasound are solitary or not visualized at all, I am obliged to tell the truth. The chances of obtaining high-quality own oocytes are minimal. You could spend months on stimulation attempts and large sums on medications and procedures, but the result will likely not be there. In such situations, I always speak about programs with donor oocytes. This is not a defeat; it is a realistic path to motherhood.
There are borderline cases where indicators are reduced but not yet critical. For example, AMH below 0.3–0.5 ng/mL and FSH 12–15 mIU/mL. Here, I discuss two options with the patient: try one or two stimulation protocols with her own cells, understanding the chances are low, or immediately consider donor programs. Another option is a mixed protocol, where the woman starts a protocol to grow her own oocytes while a donor is prepared simultaneously (details in separate articles). The choice always remains with the woman, but she makes it while possessing full information.
Separately, I want to mention irregular cycles or the onset of menopause. If you haven't had a period for several months or cycles have become irregular (once every 2–3 months), this is a warning sign. You need to urgently test for hormones. Sometimes we still manage to catch the moment when the reserve is critically low but a few oocytes can still be retrieved. But if menopause has already occurred, there have been no periods for six months or more, and FSH is constantly held above 30–40 mIU/mL, pregnancy with own oocytes is impossible.
At What AMH Levels Will Even IVF Not Help?
The critical boundary is an AMH below 0.1 ng/mL combined with an FSH above 25 mIU/mL and the absence of visualized antral follicles. At these figures, the probability of obtaining even one oocyte after stimulation is less than 5 percent, and the probability that this oocyte will be high quality and lead to pregnancy is even lower. I am not saying this is an absolute zero—medicine knows individual cases of miracles—but I cannot build plans on that. My task is to give you a realistic assessment of the situation.
I should note that I have had pregnancies with 0.01, but in the presence of antral follicles and an FSH below 10 (as usually happens in cases of Premature Ovarian Insufficiency in patients under 35).
Donor Oocytes: When Is This the Only Option?
A donor program becomes the only realistic path to motherhood in several situations: when AMH is below 0.1 ng/mL, when after two or three stimulation attempts we failed to obtain quality oocytes, when a woman is already over 44–45 and the reserve is exhausted, or when early menopause has occurred. Yes, for many, it is psychologically difficult to accept that the child will not be genetically yours. But I always remind you: you will carry this child for nine months, your body will form them, you will give birth, breastfeed, and raise them. This is your child in every sense except the genetic one. And the success rates in donor programs are significantly higher—about 50–60 percent even for women over 40, because we are working with young, high-quality oocytes.
We can also add the option of a mixed protocol, where the woman begins a protocol to grow her own eggs and a donor is prepared at the same time (details in separate issues).
A Realistic Action Plan
What to do if the tests show a low reserve? First—do not panic, but do not lose time either. A low reserve does not mean zero chances, but it does mean you need to act quickly. If AMH is in the range of 0.1 ng/mL or lower, I suggest trying one, maximum two IVF protocols with your own oocytes, using mild stimulation or natural cycle protocols. Simultaneously, we immediately discuss "Plan B"—donor programs or adoption—so that you are mentally prepared for different scenarios. The main thing is not to get stuck in endless attempts if there is no result.
What options are there besides own oocytes? Donor oocytes are the most common and effective option for an exhausted ovarian reserve. The donor can be an anonymous young woman from the clinic's database, or a relative or acquaintance if you so decide. The second option is embryos obtained from other couples who have undergone IVF (embryo donation). The third path, if the problem is not only in the eggs but also in the inability to carry a pregnancy, is surrogacy using donor oocytes or your own if they were frozen previously.
How many attempts are needed on average at my age? Statistics show that women aged 38–40 on average require 2–3 IVF attempts to achieve pregnancy if the ovarian reserve is satisfactorily preserved. After 41–42, it is 3–4 attempts, and sometimes more. But an individual approach is critical here: if after the first attempt we see that the response to stimulation is poor, few oocytes are retrieved, or their quality is unsatisfactory, I do not recommend persisting until a fourth or fifth attempt. Time is your main resource, and if reserve indicators continue to decline, it is better to switch in time to donor programs where chances are consistently higher.
Over the years of practice, I have realized one thing: women come to me not for consolation, but for the truth. Yes, this truth can be harsh. But it is what allows for an informed decision and ensures that precious time is not lost. Each of my patients receives a clear action plan based on the specific figures of her tests. Because diagnostics is not just a set of studies; it is the map of your reproductive health, by which we together seek the optimal route to a desired pregnancy.
